Does BUMETANIDE Cause Ventricular hypertrophy? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Ventricular hypertrophy have been filed in association with BUMETANIDE (Bumetanide). This represents 0.3% of all adverse event reports for BUMETANIDE.
6
Reports of Ventricular hypertrophy with BUMETANIDE
0.3%
of all BUMETANIDE reports
3
Deaths
5
Hospitalizations
How Dangerous Is Ventricular hypertrophy From BUMETANIDE?
Of the 6 reports, 3 (50.0%) resulted in death, 5 (83.3%) required hospitalization.
Is Ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BUMETANIDE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does BUMETANIDE Cause?
Acute kidney injury (490)
Drug ineffective (186)
Hypotension (182)
Fatigue (173)
Dehydration (170)
Dyspnoea (147)
Dizziness (129)
Weight increased (113)
Cardiac failure (97)
Renal impairment (89)
What Other Drugs Cause Ventricular hypertrophy?
AMLODIPINE (46)
PREDNISONE (37)
PANTOPRAZOLE (36)
ASPIRIN (32)
VALSARTAN (29)
CLOZAPINE (28)
ACETAMINOPHEN (27)
TIOTROPIUM (24)
ALBUTEROL (21)
ONDANSETRON (21)
Which BUMETANIDE Alternatives Have Lower Ventricular hypertrophy Risk?
BUMETANIDE vs BUPIVACAINE
BUMETANIDE vs BUPIVACAINE\BUPIVACAINE ANHYDROUS
BUMETANIDE vs BUPIVACAINE\EPINEPHRINE
BUMETANIDE vs BUPIVACAINE\MELOXICAM
BUMETANIDE vs BUPRENORPHINE